BERWYN, Pa., Jan. 30, 2023 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Pardes Biosciences, Inc. ("Pardes" or the "Company") (NASDAQ:PRDS) investors concerning the Company's possible violations of the federal securities laws.
Read more at prnewswire.comRM LAW Announces Investigation of Pardes Biosciences, Inc.
PR Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here